JPRN-UMIN000020907已完成未知
The influence of sialidase on the management renal anemia therapy in CKD patients - SMART-CKD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 382
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Infectious disease neoplasm bleeding complications dementia
研究者
相似试验
已完成
不适用
The protective effect for renal function of Aliskiren in hypertensive CKD patients with proteinuriahypertensive patients with chronic kidney diseaseJPRN-UMIN000005759Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine153
招募中
1 期
A research study to find out how semaglutide works in the kidneys compared to placebo, in people with type 2 diabetes and chronic kidney diseaseEUCTR2020-000828-19-DKovo Nordisk A/S105
招募中
1 期
A research study to find out how semaglutide works in the kidneys compared to placebo, in people with type 2 diabetes and chronic kidney diseaseEUCTR2020-000828-19-FRovo Nordisk A/S105
进行中（未招募）
1 期
A research study to find out how semaglutide works in the kidneys compared to placebo, in people with type 2 diabetes and chronic kidney diseaseDiabetes Mellitus, Type 2Chronic kidney diseaseMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861MedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2020-000828-19-PLovo Nordisk A/S105
进行中（未招募）
1 期
A research study to find out how semaglutide works in the kidneys compared to placebo, in people with type 2 diabetes and chronic kidney diseaseDiabetes Mellitus, Type 2Chronic kidney diseaseMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861MedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2020-000828-19-ESovo Nordisk A/S105